A commercial outcome, or certainty of one.
The way this board communicates and behaves sows a lot of doubt. The only thing that will create the demand you talk of is when we are registering for a specific use and we are likely to become a standard of care.
Everything else is just more talk from a board who have proven time and again they are totally unreliable.
Ann: Motor Neurone Disease Phase 1/2 Clinical Trial Update, page-166
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $82.15M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.0¢ | 20.5¢ | $64.53K | 312.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 105748 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 100308 | 5 |
View Market Depth
| Last trade - 13.41pm 26/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |